104565-00-6

Basic information

• Product Name: 4-Chloro-5-(4-dimethylaminobenzylamino)-2-t-butyl-3(2H)-pyridazinone
• Synonyms: 4-Chloro-5-(4-dimethylaminobenzylamino)-2-t-butyl-3(2H)-pyridazinone
• CAS NO: 104565-00-6
• Molecular Weight: 334.849
• Mol File: 104565-00-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-Chloro-5-(4-dimethylaminobenzylamino)-2-t-butyl-3(2H)-pyridazinone(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-5-(4-dimethylaminobenzylamino)-2-t-butyl-3(2H)-pyridazinone(104565-00-6)
• EPA Substance Registry System: 4-Chloro-5-(4-dimethylaminobenzylamino)-2-t-butyl-3(2H)-pyridazinone(104565-00-6)

Safety Data

• Hazardous Substances Data: 104565-00-6(Hazardous Substances Data)

Upstream product

• 123-91-1 1,4-dioxane 
• 10003-74-4 4-(dimethylamino)benzylamine dihydrochloride salt 
• 84956-71-8 2-tert-butyl-4,5-dichloro-2H-pyridazin-3-one 

Relevant articles and documents

3(2H)pyridazinone, process for its preparation and anti-allergic agent containing it

A 3(2H)pyridazinone of the formula: STR1 wherein R1 is C2 -C5 alkyl; R2 is hydrogen, C1 -C3 alkyl, chlorine or bromine; R3 is hydrogen or C1 -C4 alkyl; and each of Y1, Y2 and Y3 which may be the same or different, is hydrogen, C1 -C8 alkyl, C2 -C8 alkenyl, halogen, --(CH2)l A [wherein A is substituted amino of the formula --N(R4) (R5) (wherein each of R4 and R5 which may be the same or different, is C1 -C4 alkyl, or R4 and R5 together form C4 -C6 alkylene), morpholino, 4-R6 -piperazin-1-yl (wherein R6 is C1 -C3 alkyl) or --OR7 (wherein R7 is hydrogen or C1 -C3 alkyl), and l is an integer of 0 to 3], --OR8 [wherein R8 is hydrogen, C1 -C8 alkyl, C3 -C5 alkenyl, benzyl or --(CH2)q --R9 [wherein R9 is CO2 R3 (wherein R3 is as defined above), --CONHR3 (wherein R3 is as defined above) or --CH2 OR7 (wherein R7 is as defined above), and q is an integer of 1 to 5]], --CO2 R3 (wherein R3 is as defined above), --CON(R10) (R11) [wherein each of R10 and R11 which may be the same or different, is hydrogen, C1 -C4 alkyl or C3 -C5 alkenyl, or R10 and R11 together form C4 -C6 alkylene, --(CH2)2 O(CH2)2 -- or --(CH2)2 N(R6)(CH2)2 -- (wherein R6 is as defined above)], --CONH(CH2)m A (wherein A is as defined above, and m is an integer of 2 to 4), --CH=CHCOR12 (wherein R12 is hydroxy, C1 -C4 alkoxy or --N(R13) (CH2)n CO2 R3 (wherein R13 is hydrogen, C1 -C6 alkyl or cycloalkyl, R3 is as defined above, and n is an integer of 1 to 4)), --SR14 (wherein R14 is C1 -C4 alkyl), --CN or STR2 wherein R3 is as defined above), or two of Y1, Y2 and Y3 together form STR3 (wherein p is an integer of 1 or 2), and a pharmaceutically acceptable salt thereof.